Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders

Clin Chim Acta. 1987 Jul 15;166(2-3):255-63. doi: 10.1016/0009-8981(87)90428-1.

Abstract

Since very long-chain fatty acids with a chain length of 24 carbons or more are known to accumulate in tissues and body fluids from patients with the cerebrohepato-renal (Zellweger) syndrome, infantile Refsum disease, neonatal adrenoleukodystrophy and X-linked adrenoleukodystrophy, we studied very long-chain fatty acid oxidation in cultured skin fibroblasts from these patients. In this paper, we report that in accordance with earlier results the first step in the beta-oxidation of the very long-chain fatty acid lignoceric acid (C24:0) primarily occurs in peroxisomes in control human skin fibroblasts. Furthermore, it was found that peroxisomal lignoceric acid beta-oxidation was strongly deficient in fibroblasts from patients with Zellweger syndrome, infantile Refsum disease, neonatal and X-linked adrenoleukodystrophy, which explains for the accumulation of very long-chain fatty acids in all four disease entities. In Zellweger syndrome, infantile Refsum disease and neonatal adrenoleukodystrophy the impairment in peroxisomal very long-chain fatty acid beta-oxidation is probably caused by a strong deficiency of all peroxisomal beta-oxidation enzyme proteins due to a deficiency of peroxisomes.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenoleukodystrophy / metabolism
  • Adult
  • Brain Diseases / metabolism*
  • Cells, Cultured
  • Fatty Acids / metabolism*
  • Female
  • Fibroblasts / metabolism
  • Humans
  • Kidney Diseases / metabolism*
  • Lipid Metabolism, Inborn Errors / metabolism*
  • Liver Diseases / metabolism*
  • Microbodies / metabolism*
  • Oxidation-Reduction
  • Refsum Disease / metabolism
  • Skin / metabolism
  • Syndrome

Substances

  • Fatty Acids
  • lignoceric acid